5-Thiophen-2-yl-3-m-tolyl-[1,2,4]oxadiazole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-Thiophen-2-yl-3-m-tolyl-[1,2,4]oxadiazole
• 英文别名: 3-(3-methylphenyl)-5-thiophen-2-yl-1,2,4-oxadiazole
• 化学式: C₁₃H₁₀N₂OS
• mdl: MFCD02945441
• 分子量: 242.3
• InChiKey: DDOWOMLCCSJYMZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  67.2
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Compostions and Methods for Controlling Nematodes
  申请人：Williams Deryck J.

  公开号：US20090048311A1

  公开（公告）日：2009-02-19

  Compositions and processes for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.

  本文描述了用于控制线虫的组合物和过程，例如侵害植物或动物的线虫。这些化合物包括噁唑、噁二唑和噻二唑。
• [EN] COMPOSITIONS AND METHODS FOR IMPROVING AGRONOMIC CHARACTERISTICS OF PLANTS<br/>[FR] COMPOSITIONS ET PROCÉDÉS DESTINÉS À AMÉLIORER DES CARACTÉRISTIQUES AGRONOMIQUES DE PLANTES
  申请人：MONSANTO TECHNOLOGY LLC

  公开号：WO2016100766A1

  公开（公告）日：2016-06-23

  Compounds, compositions and methods for improving one or more agronomic characteristics of desired crop plants are described herein. The compounds include oxazoles, oxadiazoles and thiadiazoles.

  本文描述了改善所需作物植物一种或多种农艺特性的化合物、组合物和方法。这些化合物包括噁唑、噁二唑和噻二唑。
• COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES
  申请人：Monsanto Technology LLC

  公开号：US20130296166A1

  公开（公告）日：2013-11-07

  Compositions and processes for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.

  本文描述了用于控制寄生在植物或动物上的线虫的组合物和过程，例如包括噁唑、噁二唑和噻二唑的化合物。
• BRCA1-BASED BREAST OR OVARIAN CANCER PREVENTION AGENTS AND METHODS OF USE
  申请人：Jensen Roy A.

  公开号：US20090170842A1

  公开（公告）日：2009-07-02

  A pharmaceutical composition for use in treating, inhibiting, and/or preventing breast and/or ovarian cancer can include: a molecule having a structure of one of Compounds 1-38, pharmaceutically acceptable salt thereof, or analog thereof, and a pharmaceutically acceptable carrier containing the compound. The pharmaceutically acceptable carrier can be configured for oral, systemic, transdermal, intranasal, suppository, parenteral, intramuscular, intravenous, or subcutaneous administration. The compound can be present in the composition in a therapeutically effective amount for treating, inhibiting, and/or preventing breast and/or ovarian cancer. Also, the compound can be present in a therapeutically effective amount for enhancing production of BRCA1.

  一种用于治疗、抑制和/或预防乳腺和/或卵巢癌的药物组合物可以包括：具有化合物1-38中一种的结构，其药学上可接受的盐或类似物，以及含有该化合物的药学上可接受的载体。药学上可接受的载体可以配置为口服、全身性、经皮、鼻内、栓剂、静脉注射、肌肉注射或皮下注射的给药途径。该化合物可以以治疗、抑制和/或预防乳腺和/或卵巢癌的治疗有效量存在于组合物中。此外，该化合物可以以增强BRCA1产生的治疗有效量存在于组合物中。
• Compositions and methods for controlling nematodes
  申请人：Monsanto Technology LLC

  公开号：US10375958B2

  公开（公告）日：2019-08-13

  Compositions and methods for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.

  本文描述了用于控制线虫（如侵染植物或动物的线虫）的化合物和方法。这些化合物包括噁唑类、噁二唑类和噻二唑类。